Related Experiment Video
Updated: May 20, 2026
05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
Next-Generation Protein Therapeutics Summit conference report
1MannKind Corporation, I Casper Street, Danbury, CT 06810, USA. aleone-bay@mannkindcorp.com
Therapeutic Delivery
|July 25, 2012
Summary
The 2011 Next-Generation Protein Therapeutics Summit explored five key strategies for advancing protein and biologic drugs. Focus areas included novel therapeutics, property enhancements, administration routes, immunogenicity reduction, and non-natural amino acid applications.
Area of Science:
- Biopharmaceutical development
- Drug discovery and design
Background:
- The 2011 Next-Generation Protein Therapeutics Summit convened experts to discuss advancements in protein and biologic drug development.
- The summit addressed critical challenges and opportunities in creating next-generation therapeutics.
Framework:
- Focused on five strategic approaches for designing and realizing advanced protein and biologic drugs.
- Covered both antibody and non-antibody based therapeutics.
- Explored innovations in improving physicochemical properties of therapeutic proteins.
Implementation:
- Discussed novel routes of administration for enhanced drug delivery.
- Highlighted methodologies for reducing immunogenic reactions to protein therapeutics.
- Examined the development of novel drugs utilizing non-natural amino acids.
Implications:
- The summit's discussions provide a strategic roadmap for future biopharmaceutical innovation.
- Advancements in protein therapeutics promise more effective and safer treatment options.
- Integration of non-natural amino acids opens new avenues for drug design and function.
Related Concept Videos
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...